Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person VEGFR-3 preferentially binds VEGF-C and -D. Mutations of the...
| Class:Id | Summation:195563 |
|---|---|
| _displayName | VEGFR-3 preferentially binds VEGF-C and -D. Mutations of the... |
| _timestamp | 2008-02-27 18:31:46 |
| created | [InstanceEdit:195566] Gopinathrao, G, 2007-04-09 01:56:10 |
| literatureReference | [LiteratureReference:195439] Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis |
| modified | [InstanceEdit:195582] Gopinathrao, G, 2007-04-09 02:04:07 [InstanceEdit:195642] Gopinathrao, G, 2007-04-11 20:35:02 [InstanceEdit:215138] Gopinathrao, G, 2008-02-27 18:32:21 |
| text | VEGFR-3 preferentially binds VEGF-C and -D. Mutations of the VEGFR-3 tyrosine kinase domain are seen in human lymphedema. VEGFR-3 expression has been correlated with transient lymphangiogenesis in wound healing and may modulate VEGFR-2 signaling in maintaining vascular integrity (Hicklin and Ellis 2005). |
| (summation) | [Reaction:194308] VEGF-C,D bind to VEGFR3 leading to receptor dimerization [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by VEGFR-3 preferentially binds VEGF-C and -D. Mutations of the... (195563)
